Financial statements Endokrynologia
Balance sheet data of ENDOKRYNOLOGIA
|
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 067 299,84 | 922 561,70 | 676 219,02 | 848 973,11 | 1 063 260,20 |
| A. Fixed assets | 125 101,66 | 197 461,77 | 181 465,69 | 158 631,19 | 53 703,19 |
| B. Current assets | 942 198,18 | 725 099,93 | 494 753,33 | 690 341,92 | 1 009 557,01 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 1 067 299,84 | 922 561,70 | 676 219,02 | 848 973,11 | 1 063 260,20 |
| A. Equity | 977 591,64 | 837 048,74 | 505 424,54 | 616 235,65 | 849 917,04 |
| B. Liabilities and provisions for liabilities | 89 708,20 | 85 512,96 | 170 794,48 | 232 737,46 | 213 343,16 |
| I. Long-term liabilities | 0,00 | 0,00 | 13 500,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 89 708,20 | 85 512,96 | 157 294,48 | 232 737,46 | 213 343,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.